You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 21 Sep 655.15 -14.25
(-2.13%)
OPEN

675.00

HIGH

681.25

LOW

632.25

NSE 00:00 | 21 Sep 654.80 -15.85
(-2.36%)
OPEN

674.50

HIGH

682.70

LOW

632.00

OPEN 675.00
PREVIOUS CLOSE 669.40
VOLUME 79466
52-Week high 711.55
52-Week low 483.60
P/E 16.20
Mkt Cap.(Rs cr) 18,488
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 675.00
CLOSE 669.40
VOLUME 79466
52-Week high 711.55
52-Week low 483.60
P/E 16.20
Mkt Cap.(Rs cr) 18,488
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is a research-driven global integrated pharmaceutical company. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology Respiratory and Dermatology. Its branded...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   18,488
EPS - TTM () [*S] 40.43
P/E Ratio (X) [*S] 16.20
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 19 Sep 2018
Dividend Yield (%) 0.31
Book Value / Share () [*S] 368.24
P/B Ratio () [*S] 1.78
[*C] Consolidated     [*S] Standalone    

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Jun 2018 Jun 2017 % Chg
Net Sales 2165.62 2363 -8.35
Other Income 138.22 15.29 803.99
Total Income 2303.83 2378.29 -3.13
Total Expenses 1818.73 1785.55 1.86
Operating Profit 485.1 592.74 -18.16
Net Profit 232.99 333.38 -30.11
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Torrent Pharma. 1727.95 -1.50 29240.37
Glaxosmi. Pharma 1623.55 -1.65 27504.56
Alkem Lab 2080.80 0.84 24875.96
Glenmark Pharma. 655.15 -2.13 18488.33
Abbott India 8233.20 -2.23 17495.55
Sanofi India 6487.60 2.57 14940.94
Natco Pharma 788.10 1.38 14540.45
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.54
Banks/FIs 2.74
FIIs 30.61
Insurance 0.00
Mutual Funds 4.01
Indian Public 10.71
Custodians 0.00
Other 5.20
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
03/05 HDFC Securities Buy 894 PDF IconDetails
20/12 IDBI Capital Accumulate 941 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -5.17% -5.42% -3.28% -3.23%
1 Month 3.29% 2.97% -3.77% -3.70%
3 Month 8.87% 8.76% 3.98% 3.74%
6 Month 20.21% 20.12% 11.18% 9.73%
1 Year 4.20% 4.15% 13.81% 10.09%
3 Year -35.92% -35.98% 40.65% 39.69%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 632.25
681.25
Week Low/High 632.25
705.00
Month Low/High 607.60
712.00
YEAR Low/High 483.60
712.00
All TIME Low/High 1.89
1262.00